Elite Pharmaceuticals Market Cap

Elite Pharmaceuticals has a market cap or net worth of $496.27 million as of March 26, 2025. Its market cap has increased by 216.62% in one year.

Market Cap

496.27M

Enterprise Value

499.25M

Revenue

70.00M

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.46

Market Cap Chart

Since July 23, 1998, Elite Pharmaceuticals's market cap has increased from 9.58M to 496.27M, an increase of 5,082.82%. That is a compound annual growth rate of 15.94%.

Market Cap History

Date	Market Cap	% Change
Mar 24, 2025	494.72M	-14.42%
Dec 31, 2024	578.04M	306.60%
Dec 29, 2023	142.16M	374.74%
Dec 30, 2022	29.95M	-10.40%
Dec 31, 2021	33.42M	-36.49%
Dec 31, 2020	52.63M	-31.72%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.94B
SS Innovations International	1.76B
Nika Pharmaceuticals	1.02B
Veradigm	720.71M
Glass House Brands	367.15M
Northwest Biotherapeutics	325.57M
CytoDyn	295.65M
BioStem Technologies	171.54M

Market Cap Rankings